ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,583Medicare Part D Prescriptions Filled, Including Refills

Rank: 133 out of 1206

$465K Total Retail Price of All Prescriptions

Rank: 202 out of 1206

359 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
37% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Iowa
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 359 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

10% of this provider’s 359 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

2% of this provider’s 9,942 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$40 was the average price of a prescription from this provider, compared to $46 among peers.

Prescriptions per Patient

32 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Iowa
WARFARIN SODIUM 589 500 1 8
METFORMIN HCL 547 454 2 10
LEVOTHYROXINE SODIUM 532 455 3 2
SIMVASTATIN 457 414 4 1
FUROSEMIDE 338 306 5 5
OMEPRAZOLE 334 231 6 3
AMLODIPINE BESYLATE 281 251 7 6
LISINOPRIL 278 245 8 4
HYDROCHLOROTHIAZIDE 276 268 9 11
POTASSIUM CHLORIDE 235 196 10 12
ALENDRONATE SODIUM 226 212 11 19
ATORVASTATIN CALCIUM 211 209 12 13
TRAMADOL HCL 192 165 13 17
METOPROLOL TARTRATE 173 171 14 9
ATENOLOL 168 160 15 14
METOPROLOL SUCCINATE 140 131 16 15
HYDROCODONE-ACETAMINOPHEN 128 119 S3 17 7
RAMIPRIL 116 116 18 96
CITALOPRAM HBR 113 108 19 16
ENALAPRIL MALEATE 106 92 20 45
MIRTAZAPINE 104 92 21 50
GLIMEPIRIDE 100 88 22 34
ALLOPURINOL 94 94 23 24
OXYBUTYNIN CHLORIDE 92 77 24 68
BENAZEPRIL HCL 90 78 25 39
DONEPEZIL HCL 86 86 26 29
CRESTOR 84 61 27 30
CARVEDILOL 84 80 27 32
LISINOPRIL-HYDROCHLOROTHIAZIDE 83 83 29 27
INDAPAMIDE 82 74 30 178
PAROXETINE HCL 80 80 31 53
PROPRANOLOL HCL 76 71 32 92
DILTIAZEM 24HR CD 72 58 33 67
LOVASTATIN 71 71 34 44
NAMENDA 70 69 35 36
POLYETHYLENE GLYCOL 3350 68 64 36 31
DIGOXIN 66 61 37 43
AMITRIPTYLINE HCL 65 45 R 38 59
TRIAMTERENE-HCTZ 64 64 39 33
ADVAIR DISKUS 64 57 39 55
GEMFIBROZIL 64 54 39 71
RANITIDINE HCL 62 35 42 23
SERTRALINE HCL 62 62 42 22
TRIMETHOPRIM 60 60 44 234
TRAZODONE HCL 59 37 45 37
LOSARTAN POTASSIUM 58 55 46 20
TRIAMCINOLONE ACETONIDE 58 56 46 102
DIOVAN HCT 57 57 48 112
BUPROPION HCL SR 55 43 49 171
SPIRONOLACTONE 54 44 50 41
CARBIDOPA-LEVODOPA 54 54 50 70
CIPROFLOXACIN HCL 53 45 52 61
BENAZEPRIL-HYDROCHLOROTHIAZIDE 52 52 53 133
TRICOR 52 37 53 130
GLIPIZIDE 50 36 55 64
ALBUTEROL SULFATE 50 49 55 123
PREDNISONE 50 49 55 28
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.